Thank you for your interest in Cell Proliferation. Please note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting on symposium.
New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/CPR. You may check the status of your submission at any time by logging on to submission.wiley.com and clicking the "My Submissions" button. For technical help with the submission system, please review our FAQs or contact submissionhelp@wiley.com.
For help with submissions, please contact: CPReditorialoffice@wiley.com
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
Cell Proliferation offers Free Format submission for a simplified and streamlined submission process.
Before you submit, you will need:
Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions (For details, see Section 2). Figures and tables should have legends. Figures should be uploaded in the highest resolution possible (For details, see Section 1.11). If the figures are not of sufficiently high quality, your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
This journal is a Gold Open Access journal. Submissions will be subject to an APC if accepted and published in the journal. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page.
Please find the Wiley preprint policy here.
This journal accepts articles previously published on preprint servers.
Cell Proliferation will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article immediately after publication.
When you submit a manuscript to this journal, it is imperative to follow the guidelines regarding data sharing, citation, and protection as outlined below:
You should list all funding sources in the Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.
If excerpts from copyrighted works owned by third parties are included, all sources must be credited within the manuscript. At minimum, the title and author should be provided.
The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon request
For more information, review Wiley’s Guidelines for Obtaining Permission to Reproduce Material.
The title page of the manuscript, including: Your co-author details, affiliation, email address, and so on. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
Figures, supporting information, and appendices should be supplied as separate files. You should review the basic figure requirements for manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. View Wiley’s FAQs on supporting information.
Graphical Abstract is mandatory for original article or review article, while optional for other article types. It is a single, concise visual summary of the main topics and if possible key findings of the article to draw the reader to the whole paper. In our submission system, you are required to submit the following items separately:
(1) A short statement of 50 words or less (1-2 sentences) to be published in the Table of Contents that describes the key findings and main message of the work. This caption will appear alongside the Graphical Abstract Image that you provide as a separate file.
(2) An illustration to be published in the Table of Contents to assist non-specialists in understanding the context and significance of your research. The image supplied should fit within the dimensions of 50 mm x 60 mm and be fully legible at this size. This image will be captioned with the Graphical Abstract Text that you supply as a separate file;
Graphical Abstracts can be shared and reproduced via all social media without limitation, for the benefit of spreading important research information.
Authors are responsible for obtaining permission to use any images that they include from outside sources, including articles, web pages, stock photo sites or Google image searches. Any needed permissions must be submitted along with your graphical abstract or identified in the Acknowledgements section of your manuscript.
For authors requiring a LaTeX template, we strongly recommend reviewing Wiley’s New Journal Design (NJD) LaTeX Authoring Template.
LaTeX Guidelines for Post-Acceptance:
Please check that you have supplied the following files for typesetting post-acceptance:
This journal operates a single-anonymized peer review policy. Except where otherwise stated, manuscripts are peer reviewed by at least two anonymous reviewers and an Associate or Assistant Editor. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.
Wiley's policy on the confidentiality of the review process is available here.
Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.
Authors may appeal an editorial decision if they feel that the decision to reject was based on either a significant misunderstanding of a core aspect of the manuscript, a failure to understand how the manuscript advances the literature or concerns regarding the manuscript-handling process. Differences in opinion regarding the novelty or significance of the reported findings are not considered as grounds for appeal. To raise an appeal, please contact this journal by email, quoting your manuscript ID number and explaining your rationale for the appeal. The editor’s decision following an appeal consideration is final.
To raise a complaint regarding editorial staff, policy or process please contact the journal in the first instance. If you believe further support outside the journal’s management is necessary, please refer to Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics.
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), nor do they have legal standing or the ability to hold or assign copyright. Therefore—in accordance with COPE’s position statement on AI tools—these tools cannot fulfill the role of, nor be listed as, an author of an article. If an author has used this kind of tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods or Acknowledgements section. The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. The final decision about whether use of an AIGC tool is appropriate or permissible in the circumstances of a submitted manuscript or a published article lies with the journal’s editor or other party responsible for the publication’s editorial policy.
When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. You will be asked to sign a publication license at this point as well as pay for any applicable APCs.
Cell Proliferation is an Open Access journal: authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. Note that certain funders mandate a particular type of CC license be used. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page.
After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.
This journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
You will be asked to use RRIDs to cite the resources used in your research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, you should include in the citation the vendor, catalogue number, and RRID both in the text and upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.
Additionally, you must include the RRIDs in the list of keywords associated with the manuscript.
If there is a resource that is not found within the Resource Identification Portal, you are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.
If any difficulties in obtaining identifiers arise, please contact rii-help@scicrunch.org for assistance.
Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"
Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"
Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"
Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"
Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:
Proteins sequence data should be submitted to either of the following repositories:
For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.
This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.
Wiley Editing Services offers a professional cover image design service that creates eye-catching images, ready to be showcased on the journal cover.
Additional Guidelines for Cover Pictures, Visual Abstracts, Frontispieces and Table of Contents Graphics
Graphics that do not adhere to these guidelines will be recommended for revision or will not be accepted for publication.
This journal has the option for authors to embed rich media (i.e. video and audio) within their final article. These files should be submitted with the manuscript files online, using either the “Embedded Video” or “Embedded Audio” file designation. If the video/audio includes dialogue, a transcript should be included as a separate file. Maximum file size is 300 MB, and the combined manuscript files, including video, audio, tables, figures, and text must not exceed 350 MB. For full guidance on accepted file types and resolution please see here.
Ensure each file is numbered (e.g. Video 1, Video 2, etc.). Legends for the rich media files should be placed at the end of the article.
The content of the video should not display overt product advertising. Educational presentations are encouraged.
Any narration should be in English, if possible. A typed transcript of any speech within the video/audio should be provided. An English translation of any non-English speech should be provided in the transcript.
All embedded rich media will be subject to peer review. Editors reserve the right to request edits to rich media files as a condition of acceptance. Contributors are asked to be succinct, and the Editors reserve the right to require shorter video/audio duration. The video/audio should be high quality (both in content and visibility/audibility). The video/audio should make a specific point; particularly, it should demonstrate the features described in the text of the manuscript.
Participant Consent: It is the responsibility of the corresponding author to seek informed consent from any identifiable participant in the rich media files. Masking a participant’s eyes, or excluded head and shoulders is not sufficient. Please ensure that a consent form (https://authorservices.wiley.com/author-resources/Journal-Authors/licensing/licensing-info-faqs.html) is provided for each participant.
The Plain Language Summary (PLS) should convey the same information as the Abstract but in a completely different language and tone. It should summarize your scientific study, its results, and their broader relevance without using jargon so that it is understandable by scientists from outside of your discipline, as well as science journalists and science educators. The PLS should be a single paragraph no more than 200 words long.